Rivaroxaban (Xarelto) for the prevention of venous thromboembolism (VTE): SMC review
The Scottish Medicines Consortium issued on 7th November, 2008 an advice on rivaroxaban (Xarelto): ADVICE: following a full submissionrivaroxaban (Xarelto®) is accepted for use within NHS Scotland for the prevention of venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.In three large phase III studies in patients undergoing either total knee […]